{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:12:56Z","timestamp":1785265976463,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rabies (RABV) is an enzootic disease in Tunisia, with dogs being the primary reservoir. Vaccinating dogs is the key to eradicate rabies. Regional Veterinary Services conduct nationwide immunisation campaigns on an annual basis. Evaluation of the immune response is still important to make sure that the vaccination is effective in the conditions of the Tunisian field. In this paper, the FAVN technique was used to test rabies antibody dynamics in dogs from three distinct Tunisian areas observed for one year following a mass vaccination campaign.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>On day 30 after vaccination, 75% of all dogs vaccinated during the campaign were sero-positive (titres greater than or equal to 0.5 transformed IU\/ml). On day 180, 48% of all dogs were sero-positive. Only 25.6% of primary-vaccinated dogs remained sero-positive on day 180 and 7% on day 365, whereas 91% of previously sero-positive dogs remained sero-positive on day 365.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although a single rabies vaccine is successful at stimulating an immunological response, it is recommended that primary-vaccinated dogs have a second booster between one and three months after the initial vaccination to maintain seropositivity. To achieve the rabies eradication objective, all dogs should receive an annual booster to maintain effective immunological protection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12917-023-03582-8","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T09:04:29Z","timestamp":1675069469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of the immune response of dogs after a mass vaccination campaign against rabies in Tunisia"],"prefix":"10.1186","volume":"19","author":[{"given":"Mariem","family":"Handous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imed","family":"Turki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdejelil","family":"Ghram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"BenMaiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihen","family":"Bensalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourhene","family":"Basdouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Bassalah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Kharmachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"3582_CR1","unstructured":"Rabies. [cited 22 Mar 2021]. Available: https:\/\/www.who.int\/westernpacific\/health-topics\/rabies"},{"key":"3582_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0264-410X(95)00197-9","volume":"14","author":"PG Coleman","year":"1996","unstructured":"Coleman PG, Dye C. Immunization coverage required to prevent outbreaks of dog rabies. Vaccine. 1996;14:185\u20136. https:\/\/doi.org\/10.1016\/0264-410X(95)00197-9.","journal-title":"Vaccine"},{"key":"3582_CR3","first-page":"167","volume":"131","author":"CHA Lucas","year":"2008","unstructured":"Lucas CHA, Pino FV, Baer G, Morales PK, Cedillo VG, Blanco MAL, et al. Rabies control in Mexico. Dev Biol. 2008;131:167\u201375.","journal-title":"Dev Biol"},{"key":"3582_CR4","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.1371\/journal.pntd.0000626","volume":"4","author":"T Lembo","year":"2010","unstructured":"Lembo T, Hampson K, Kaare MT, Ernest E, Knobel D, Kazwala RR, et al. The Feasibility of Canine Rabies Elimination in Africa: Dispelling Doubts with Data. PLoS Negl Trop Dis. 2010;4:e626. https:\/\/doi.org\/10.1371\/journal.pntd.0000626.","journal-title":"PLoS Negl Trop Dis."},{"key":"3582_CR5","doi-asserted-by":"publisher","first-page":"eaaf6984","DOI":"10.1126\/scitranslmed.aaf6984","volume":"9","author":"J Zinsstag","year":"2017","unstructured":"Zinsstag J, Lechenne M, Laager M, Mindekem R, Na\u00efssengar S, Oussigu\u00e9r\u00e9 A, et al. Vaccination of dogs in an African city interrupts rabies transmission and reduces human exposure. Sci Transl Med. 2017;9:eaaf6984. https:\/\/doi.org\/10.1126\/scitranslmed.aaf6984.","journal-title":"Sci Transl Med."},{"key":"3582_CR6","volume-title":"WHO Expert Consultation on Rabies: third report","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. WHO Expert Consultation on Rabies: third report. Geneva: World Health Organization; 2018."},{"key":"3582_CR7","doi-asserted-by":"publisher","first-page":"e0007869","DOI":"10.1371\/journal.pntd.0007869","volume":"13","author":"S Jeon","year":"2019","unstructured":"Jeon S, Cleaton J, Meltzer MI, Kahn EB, Pieracci EG, Blanton JD, et al. Determining the post-elimination level of vaccination needed to prevent re-establishment of dog rabies. PLoS Negl Trop Dis. 2019;13:e0007869. https:\/\/doi.org\/10.1371\/journal.pntd.0007869.","journal-title":"PLoS Negl Trop Dis."},{"key":"3582_CR8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1863-2378.2008.01126.x","volume":"55","author":"K Suzuki","year":"2008","unstructured":"Suzuki K, Gonz\u00e1lez ET, Ascarrunz G, Loza A, P\u00e9rez M, Ruiz G, et al. Antibody response to an anti-rabies vaccine in a dog population under field conditions in Bolivia. Zoonoses Public Health. 2008;55:414\u201320. https:\/\/doi.org\/10.1111\/j.1863-2378.2008.01126.x.","journal-title":"Zoonoses Public Health"},{"key":"3582_CR9","unstructured":"9-tunisie_pasteur-institute-of-tunis.pdf. Available: https:\/\/rr-africa.oie.int\/wp-content\/uploads\/2019\/07\/9-tunisie_pasteur-institute-of-tunis.pdf"},{"key":"3582_CR10","unstructured":"Comit\u00e9 national de lutte contre la rage de Tunisie. Bulletins \u00e9pid\u00e9miologiques de la rage de Tunisie."},{"key":"3582_CR11","unstructured":"Institut Pasteur de Tunis. Rapports des laboratoires et services de l\u2019Institut Pasteur de Tunis. Available: http:\/\/www.pasteur.tn\/index.php?option=com_content&view=article&id=310&Itemid=639"},{"key":"3582_CR12","first-page":"84","volume-title":"Expert committee on rabies, 8th report","author":"World Health Organization","year":"1992","unstructured":"World Health Organization. Expert committee on rabies, 8th report. 1992. p. 84."},{"key":"3582_CR13","unstructured":"BCM Mai 2020 fr.pdf. Available: https:\/\/www.meteo.tn\/sites\/default\/files\/2020-06\/BCM%20Mai%202020%20fr.pdf"},{"key":"3582_CR14","doi-asserted-by":"publisher","first-page":"728271","DOI":"10.3389\/fvets.2021.728271","volume":"8","author":"A Lugelo","year":"2021","unstructured":"Lugelo A, Hampson K, Czupryna A, Bigambo M, McElhinney LM, Marston DA, et al. Investigating the Efficacy of a Canine Rabies Vaccine Following Storage Outside of the Cold-Chain in a Passive Cooling Device. Front Vet Sci. 2021;8:728271. https:\/\/doi.org\/10.3389\/fvets.2021.728271.","journal-title":"Front Vet Sci."},{"key":"3582_CR15","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.vaccine.2016.08.045","volume":"35","author":"A Ashok","year":"2017","unstructured":"Ashok A, Brison M, LeTallec Y. Improving cold chain systems: Challenges and solutions. Vaccine. 2017;35:2217\u201323. https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.045.","journal-title":"Vaccine"},{"key":"3582_CR16","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.vaccine.2014.10.080","volume":"33","author":"J Lloyd","year":"2015","unstructured":"Lloyd J, Lydon P, Ouhichi R, Zaffran M. Reducing the loss of vaccines from accidental freezing in the cold chain: The experience of continuous temperature monitoring in Tunisia. Vaccine. 2015;33:902\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2014.10.080.","journal-title":"Vaccine"},{"key":"3582_CR17","first-page":"63","volume":"18","author":"N Haddad","year":"1987","unstructured":"Haddad N. Serological evaluation of the efficacy of an antirabies vaccine in field dogs in Tunisia. Ann Rech V\u00e9t Ann Vet Res. 1987;18:63\u20137.","journal-title":"Ann Rech V\u00e9t Ann Vet Res"},{"key":"3582_CR18","doi-asserted-by":"publisher","first-page":"879","DOI":"10.4269\/ajtmh.1999.61.879","volume":"61","author":"C Seghaier","year":"1999","unstructured":"Seghaier C, Tlatli A, Aubert M, Cliquet F, Hammami S, Aouina T. Rabies mass vaccination campaigns in Tunisia: are vaccinated dogs correctly immunized? Am J Trop Med Hyg. 1999;61:879\u201384. https:\/\/doi.org\/10.4269\/ajtmh.1999.61.879.","journal-title":"Am J Trop Med Hyg"},{"key":"3582_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/vr.154.14.423","volume":"154","author":"KL Mansfield","year":"2004","unstructured":"Mansfield KL, Sayers R, Fooks AR, Burr PD, Snodgrass D. Factors affecting the serological response of dogs and cats to rabies vaccination. Vet Rec. 2004;154:423\u20136. https:\/\/doi.org\/10.1136\/vr.154.14.423.","journal-title":"Vet Rec"},{"key":"3582_CR20","doi-asserted-by":"publisher","first-page":"8500","DOI":"10.1016\/j.vaccine.2007.10.015","volume":"25","author":"LJ Kennedy","year":"2007","unstructured":"Kennedy LJ, Lunt M, Barnes A, McElhinney L, Fooks AR, Baxter DN, et al. Factors influencing the antibody response of dogs vaccinated against rabies. Vaccine. 2007;25:8500\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.015.","journal-title":"Vaccine"},{"key":"3582_CR21","first-page":"431","volume":"131","author":"V Jakel","year":"2008","unstructured":"Jakel V, K\u00f6nig M, Cussler K, Hanschmann K, Thiel H-J. Factors influencing the antibody response to vaccination against rabies. Dev Biol. 2008;131:431\u20137.","journal-title":"Dev Biol"},{"key":"3582_CR22","doi-asserted-by":"publisher","first-page":"e0005761","DOI":"10.1371\/journal.pntd.0005761","volume":"11","author":"RM Wallace","year":"2017","unstructured":"Wallace RM, Pees A, Blanton JB, Moore SM. Risk factors for inadequate antibody response to primary rabies vaccination in dogs under one year of age. Rupprecht CE PLoS Negl Trop Dis. 2017;11:e0005761. https:\/\/doi.org\/10.1371\/journal.pntd.0005761.","journal-title":"Rupprecht CE. PLoS Negl Trop Dis."},{"key":"3582_CR23","unstructured":"Koutchoukali MA, Blancou J, Chappuis G, Tixier G, Eloit M, Ganiere JP, et al. R\u00e9ponse s\u00e9rologique du chien apr\u00e8s primovaccination antirabique a l\u2019aide de vaccins adjuv\u00e9s ou non. 1985; 7."},{"issue":"Suppl 1","key":"3582_CR24","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.jcpa.2007.04.005","volume":"137","author":"MJ Day","year":"2007","unstructured":"Day MJ. Immune system development in the dog and cat. J Comp Pathol juill. 2007;137(Suppl 1):S10-15.","journal-title":"J Comp Pathol juill"},{"key":"3582_CR25","doi-asserted-by":"publisher","unstructured":"Morters MK, McKinley TJ, Horton DL, Cleaveland S, Schoeman JP, Restif O, et al. Achieving Population-Level Immunity to Rabies in Free-Roaming Dogs in Africa and Asia. PLoS Negl Trop Dis. 2014;8.\u00a0https:\/\/doi.org\/10.1371\/journal.pntd.0003160","DOI":"10.1371\/journal.pntd.0003160"},{"key":"3582_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1136\/vr.102975","volume":"177","author":"MK Morters","year":"2015","unstructured":"Morters MK, McNabb S, Horton DL, Fooks AR, Schoeman JP, Whay HR, et al. Effective vaccination against rabies in puppies in rabies endemic regions. Vet Rec. 2015;177:150\u2013150. https:\/\/doi.org\/10.1136\/vr.102975.","journal-title":"Vet Rec"},{"key":"3582_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.vetmic.2008.06.024","volume":"133","author":"JM Minke","year":"2009","unstructured":"Minke JM, Bouvet J, Cliquet F, Wasniewski M, Guiot AL, Lemaitre L, et al. Comparison of antibody responses after vaccination with two inactivated rabies vaccines. Vet Microbiol. 2009;133:283\u20136. https:\/\/doi.org\/10.1016\/j.vetmic.2008.06.024.","journal-title":"Vet Microbiol"},{"key":"3582_CR28","doi-asserted-by":"publisher","unstructured":"Pimburage RMS, Gunatilake M, Wimalaratne O, Balasuriya A, Perera KADN. Sero-prevalence of virus neutralizing antibodies for rabies in different groups of dogs following vaccination. BMC Vet Res. 2017;13.\u00a0https:\/\/doi.org\/10.1186\/s12917-017-1038-z","DOI":"10.1186\/s12917-017-1038-z"},{"key":"3582_CR29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0264-410x(91)90186-a","volume":"9","author":"W Tepsumethanon","year":"1991","unstructured":"Tepsumethanon W, Polsuwan C, Lumlertdaecha B, Khawplod P, Hemachudha T, Chutivongse S, et al. Immune response to rabies vaccine in Thai dogs: a preliminary report. Vaccine. 1991;9:627\u201330. https:\/\/doi.org\/10.1016\/0264-410x(91)90186-a.","journal-title":"Vaccine"},{"key":"3582_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1751-0147-53-22","volume":"53","author":"LT Berndtsson","year":"2011","unstructured":"Berndtsson LT, Nyman A-KJ, Rivera E, Klingeborn B. Factors associated with the success of rabies vaccination of dogs in Sweden. Acta Vet Scand. 2011;53:22. https:\/\/doi.org\/10.1186\/1751-0147-53-22.","journal-title":"Acta Vet Scand."},{"key":"3582_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/BF03547705","volume":"36","author":"L Sihvonen","year":"1995","unstructured":"Sihvonen L, Kulonen K, Neuvonen E, Pekkanen K. Rabies antibodies in vaccinated dogs. Acta Vet Scand. 1995;36:87\u201391.","journal-title":"Acta Vet Scand"},{"key":"3582_CR32","doi-asserted-by":"publisher","unstructured":"Fernandes KG, Martins M, Amaral BP, Cargnelutti JF, Weiblen R, Flores EF. Antibodies against rabies virus in dogs with and without history of vaccination in Santa Maria - RS - Brazil. Ci\u00eanc Rural. 2017;47.\u00a0https:\/\/doi.org\/10.1590\/0103-8478cr20170125","DOI":"10.1590\/0103-8478cr20170125"},{"key":"3582_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.7774\/cevr.2016.5.1.60","volume":"5","author":"S Darkaoui","year":"2016","unstructured":"Darkaoui S, Fassi Fihri O, Schereffer JL, Aboulfidaa N, Wasniewski M, Zouine K, et al. Immunogenicity and efficacy of Rabivac vaccine for animal rabies control in Morocco. Clin Exp Vaccine Res. 2016;5:60\u20139. https:\/\/doi.org\/10.7774\/cevr.2016.5.1.60.","journal-title":"Clin Exp Vaccine Res"},{"key":"3582_CR34","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1590\/1678-5150-pvb-5997","volume":"38","author":"LM Trujillo-Rojas","year":"2018","unstructured":"Trujillo-Rojas LM, Mart\u00ednez-Gutierrez M, Ruiz-Saenz J. Low level of the immune response against rabies virus in dogs and cats, a cross-sectional study in sheltered animals, Santander. Colombia Pesqui Veterin\u00e1ria Bras. 2018;38:2109\u201316. https:\/\/doi.org\/10.1590\/1678-5150-pvb-5997.","journal-title":"Colombia Pesqui Veterin\u00e1ria Bras"},{"issue":"3","key":"3582_CR35","doi-asserted-by":"publisher","first-page":"735","DOI":"10.20506\/rst.11.3.622","volume":"11","author":"M Aubert","year":"1992","unstructured":"Aubert M. Practical significance of rabies antibodies in cats and dogs: -EN- -FR- -ES-. Rev Sci Tech OIE. 1992;11(3):735\u201360.","journal-title":"Rev Sci Tech OIE."},{"issue":"23","key":"3582_CR36","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1016\/j.vaccine.2010.03.039","volume":"28","author":"N Johnson","year":"2010","unstructured":"Johnson N, Cunningham AF, Fooks AR. The immune response to rabies virus infection and vaccination. Vaccine. 2010;28(23):3896\u2013901.","journal-title":"Vaccine."},{"key":"3582_CR37","unstructured":"Handous M. Rabies in Tunisia: the situation over 30 years. Tenth EURL workshop for rabies; 2018 juin 13; Brussels."},{"key":"3582_CR38","unstructured":"World Organization of Animal Health. Rabies (infection with Rabies virus and other lyssaviruses). OIE Terrestrial Manual;\u00a02018. p. 34. https:\/\/www.woah.org\/fileadmin\/Home\/eng\/Health_standards\/tahm\/3.01.18_RABIES.pdf."},{"key":"3582_CR39","first-page":"302","volume-title":"Laboratory techniques in rabies","author":"CE Rupprecht","year":"2018","unstructured":"Rupprecht CE, Fooks AR, Abela-Ridder B. Laboratory techniques in rabies. 5th ed. 2018. p. 302.","edition":"5th"},{"key":"3582_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","volume":"212","author":"F Cliquet","year":"1998","unstructured":"Cliquet F, Aubert M, Sagn\u00e9 L. Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J Immunol Methods. 1998;212:79\u201387. https:\/\/doi.org\/10.1016\/S0022-1759(97)00212-3.","journal-title":"J Immunol Methods"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03582-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-023-03582-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03582-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T09:07:50Z","timestamp":1675069670000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-023-03582-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3582"],"URL":"https:\/\/doi.org\/10.1186\/s12917-023-03582-8","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]},"assertion":[{"value":"23 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prior to the commencement of the study, ethical clearance was obtained from the IPT Biomedical Ethics Committee (Decision N\u00b0 2017\/04\/I\/LR11IPT03\/V1). All experimental protocols involving animals were performed in accordance with the Guiding Principles for the Care and Use of Research Animals and Animal Research: Reporting In Vivo Experiments (ARRIVE guidelines) and with the relevant national\/international\/institutional regulations. All methods were conducted according to the ethical standards of the Declaration of Helsinki. Informed consent was obtained from all subjects and\/or their legal guardian(s) for the Questionnaire of the study. Prior to each survey and blood test, informed permission was obtained from the owners at all sites, who were kept fully aware of the study's goal, approach, and progress. Vaccination and blood sampling were only performed in the presence of the owners and following informed agreement in all situations. All study participants who handled, collected, and processed blood samples from animals received pre-exposure rabies immunisation. Animals were handled with care during blood collection to reduce pain to avoid distress.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}